Nerandomilast Improves Lung Function in Progressive Pulmonary Fibrosis: FIBRONEER-ILD
Nerandomilast met its primary end point of absolute change from baseline in forced vital capacity (FVC) vs placebo in the...
Nerandomilast met its primary end point of absolute change from baseline in forced vital capacity (FVC) vs placebo in the...